Back to Journals » Journal of Multidisciplinary Healthcare » Next-Generation Vaccines and Innovative Drug Delivery Systems: From Development to Public Health Impact
Journal of Multidisciplinary Healthcare
- View all (3205)
- Volume 19, 2026 (269)
- Volume 18, 2025 (620)
- Volume 17, 2024 (536)
- Volume 16, 2023 (392)
- Volume 15, 2022 (249)
- Volume 14, 2021 (335)
- Volume 13, 2020 (205)
- Volume 12, 2019 (106)
- Volume 11, 2018 (71)
- Volume 10, 2017 (48)
- Volume 9, 2016 (70)
- Volume 8, 2015 (58)
- Volume 7, 2014 (63)
- Volume 6, 2013 (47)
- Volume 5, 2012 (39)
- Volume 4, 2011 (49)
- Volume 3, 2010 (23)
- Volume 2, 2009 (8)
- Volume 1, 2008 (16)
Journal Articles:
- Building a Sustainable Allied Health Workforce: Recruitment, Retention, and Resilience (2)
- A Multidisciplinary Approach to Reducing Suicide Risk Among Adolescents: Strategies, Challenges, and Solutions (4)
- Global Advances in Pharmacogenomics: From Discovery to Clinical Implementation and Improved Patient Outcomes (1)
- Allied Health Matters: Showcasing Value, Driving Impact (7)
- Strengthening Multidisciplinary Healthcare Teams: Workforce Integration, Team Collaboration, and Equitable Care (1)
- Harnessing Database Mining for Advancing Clinical Practice: From Insights to Therapeutic Innovation (10)
- Cybersecurity in Healthcare: Ensuring Patient Safety and Data Privacy (2)
- Children with Disabilities and Chronic Diseases: Perspectives, Challenges, and Opportunities (6)
- Exploring the Intersection of Internet Addiction and Pain Syndromes (1)
- Advancing Pharmacogenetics in Limited Resources Countries: Affordable Testing Methods, Genetic Variability, and Clinical Implications (1)
- Unraveling AI: The Use of Interactive AI, Conversational AI, and Generative AI in Teaching and Learning or Health and Care (1)
- Crosstalk in multidisciplinary approaches for evidence-based medicine (6)
Next-Generation Vaccines and Innovative Drug Delivery Systems: From Development to Public Health Impact
Vaccines are widely recognized as a pillar of public health, saving millions of lives annually by preventing infectious diseases and contributing to herd immunity. Recently, vaccines have experienced significant growth with the advancements in nanotechnology and vaccine technologies, including mRNA vaccines, viral vector platforms, and recombinant protein vaccines. Especially with the approval of mRNA LNP vaccine for COVID 19, research in vaccines has shifted to the development of mRNA-based vaccines with the aid of lipid nanoparticle delivery systems. This Article Collection provides a multidisciplinary platform for research spanning vaccine development, delivery technologies, and their broader public health implications.